Author:
Zergiebel Stephanie,Ueberschaar Nico,Plentz Jonathan,Seeling Andreas
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Lehmann J, Mohr P, Schweikert PM, Decker M, Hoefgen B/Assignee: Friedrich-Schiller-Universität Jena, Germany. Patent: DE 10 2005 025 625 A1 2006.12.07
2. Bonnot O, Dumas N (2014) Schizophrenic disorders in adolescence. Rev Prat 64:499–504
3. Jauhar S, Johnstone M, McKenna PJ (2020) Schizophrenia Lancet 399:473–486
4. Goff DC (2021) The pharmacologic treatment of schizophrenia—2021. JAMA 325:175–176
5. Hoefgen B, Decker M, Mohr P, Schramm AM, Rostom SAF, El-Subbagh H, Schweikert PM, Rudolf DR, Kassack MU, Lehmann J (2006) Dopamine/Serotonin receptor ligands. 10:1 SAR studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist. J Med Chem 49:760–769